Clinexa is a Clinical Research Organization (CRO) dedicated to supporting pharmaceutical, biotechnology, and healthcare partners in the successful delivery of clinical trials and research programs. The company fosters a collaborative and fast-paced environment where professionals are empowered to contribute to innovative research, uphold high standards of quality and compliance, and grow their careers within the evolving clinical research and life sciences industry.

We are seeking an experienced Pharmacovigilance Manager to lead drug safety operations within a global CRO environment. The role is responsible for overseeing adverse event case processing, safety reporting activities, aggregate reports, and pharmacovigilance compliance across clinical and post-marketing products. The successful candidate will ensure all activities are performed in accordance with global regulatory requirements, internal SOPs, and client expectations.

The position will work closely with global safety teams, medical reviewers, regulatory stakeholders, and cross-functional departments to support signal detection, quality oversight, and operational excellence initiatives. Candidates with strong leadership experience in pharmacovigilance operations, people management, and global safety systems within multinational CRO or pharmaceutical environments are highly preferred.

This job posting is currently published platform validation purposes during the pre-launch phase of MedicalHealthcareJobs.com, a platform developed to support the global Healthcare and Life Sciences recruitment ecosystem. Visitors may also stay updated with the latest industry news through our website while additional employers, recruiters, and opportunities are progressively onboarded.

Healthcare professionals are encouraged to sign up as a Jobseeker and start building their career profiles while we gradually onboard employers and recruiters to bring more opportunities to the platform.

Employers and recruitment partners may register for Employer Early Access Bonus 

Feedback and suggestions are welcome at [email protected].